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Abstract
Caspase enzymes are a family of cysteine proteases that play a central role in apoptosis. Recently, it has been demonstrated
that caspases can be S-nitrosylated and inhibited by nitric oxide (NO). The present report shows that in chick embryo heart
cells (CEHC), NO donor molecules such as S-nitroso-N-acetylpenicillamine (SNAP), S-nitrosoglutathione, spermine-NO or
sodium nitroprusside inhibit caspase activity in both basal and staurosporine-treated cells. However, the inhibitory effect of
NO donors on caspase activity is accompanied by a parallel cytotoxic effect, that precludes NO to exert its antiapoptotic
capability. N-Acetylcysteine (NAC) at a concentration of 10 mM blocks depletion of cellular glutathione and cell death in
SNAP-treated CEHC, but it poorly affects the ability of SNAP to inhibit caspase activity. Consequently, in the presence of
NAC, SNAP attenuates not only caspase activity but also cell death of staurosporine-treated CEHC. These data show that
changes in the redox environment may inhibit NO-mediated toxicity, without affecting the antiapoptotic capability of NO,
mediated by inhibition of caspase enzymes. NO may thus be transformed from a killer molecule into an antiapoptotic
agent. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Nitric oxide (NO) participates in diverse biological
processes including the modulation of cell death in
which it is implicated both as a mediator of cell in-
jury and as a cytoprotective agent [1^4].
Three processes control the fate of NO and con-
sequently its e¡ect in biological systems: formation,
di¡usion and reactivity. NO is formed by the action
of constitutive calcium-dependent NO synthase
(NOS), principally expressed in neurons and endo-
thelial cells, or by inducible NOS, whose activity is
induced in several cell types after exposure to in£am-
matory stimuli [5]. NO rapidly di¡uses and, owing to
its high reactivity, may have a number of cellular
targets. NO can react with several biomolecules, typ-
ically sulfhydryl-containing molecules or redox met-
al-containing proteins and interactions with these re-
dox-sensitive sites can mediate several signaling or
cytotoxic NO actions [2,5^7].
S-Nitrosylation of proteins is an important biolog-
ical action of NO that can mediate several of its
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e¡ects [5^7]. Recently it has been shown that NO can
S-nitrosylate and inactivate caspase-3 [8] as well as
other members of the caspase family [9]. Caspases
are conserved aspartate-speci¢c proteases that play
a central role in apoptosis [10]. These enzymes are
synthesized as inactive proenzymes that are activated
by cleavage to speci¢c aspartate residues to release
smaller subunits [10]. Caspases are cysteine proteases
and, consequently, potential targets of S-nitrosyla-
tion by NO. This reaction has been demonstrated
for caspase-3, where NO causes speci¢c nitrosylation
of Cys-163, a functionally essential amino acid [8].
As a consequence, NO inhibits the activity of casp-
ase-3 and other caspases [8,9,11^16] which, depend-
ing on the cell model, could result in protection
against apoptosis [8,13,15] or in the shift of apoptotic
toward necrotic cell death [11]. Since caspases play a
pivotal role in apoptosis, NO potentially has an anti-
apoptotic capability. However, in several cell types
NO elicits toxic e¡ects, which preclude it exerting a
cytoprotective action against inducers of apoptosis.
Furthermore, NO itself may induce apoptosis [1^4],
suggesting that cell sensitivity and NO concentration
are crucial to determine the e¡ect of NO on cell
survival.
This report shows that the ability of NO donor
molecules to inhibit caspase activity in chick embryo
heart cells (CEHC) in vivo is parallel to their cyto-
toxic e¡ects. In the presence of relatively low concen-
trations of N-acetylcysteine (NAC), that protects
cells against NO-induced injury, the ability of NO
to inhibit caspase activity is partially retained, thus
transforming NO from a killer molecule into an
apoptosis-attenuating agent.
2. Materials and methods
2.1. Materials and cells
SNAP and other NO donor molecules, acetyl-Asp-
Glu-Val-Asp-amino-4-methylcoumarin (Ac-DEVD-
AMC) and other biochemicals were products of Sig-
ma. Media, cell culture supplements and fetal calf
serum were purchased from Gibco.
CEHC cultures were prepared from the hearts of
10-day-old chick embryos by a trypsin disaggrega-
tion procedure [17]. To minimize non-myocyte cell
contamination, the dissociated cells were preplated
for 2 h at 37‡C, after which unattached cells (cardi-
omyocytes) were resuspended in Dulbecco minimal
essential medium supplemented with 10% fetal calf
serum and 1% penicillin and streptomycin. 2U106
cells were seeded in 35 mm dishes and grown to
con£uence. Con£uent cultures, maintained for 20 h
in a serum-free medium, were then treated as de-
scribed. The cells were incubated at 37‡C in a hu-
midi¢ed atmosphere containing 5% CO2 and 95%
air. Cell death was evaluated by trypan blue exclu-
sion and quanti¢ed by counting 100 cells per dish
with the percent survival being de¢ned as the per-
centage of cells that excluded the dye.
2.2. Determination of caspase activity
The activity of caspase enzymes was measured by
the cleavage of the £uorogenic peptide substrate Ac-
DEVD-AMC which represents a substrate for casp-
ase-3 and other members of the caspase family
[18]. At the end of the experiment, the cells were
collected, washed in phosphate-bu¡ered saline and
suspended in 0.4 ml of lysis bu¡er consisting of
20 mM HEPES, pH 7, 5 mM dithiothreitol (DTT),
2 mM EDTA, 0.1% CHAPS, 0.1% Triton X-100,
1 mM phenylmethylsulfonyl £uoride, 1 Wg/ml each
aprotinin, pepstatin and leupeptin. The cells were
then subjected to two cycles of freeze-thawing. The
lysates were centrifuged for 10 min at 28 000Ug and
the supernatant was used as enzyme source. Ten mi-
croliters of this extract (containing about 10 Wg of
protein) were combined with 20 Wl of assay bu¡er
containing 100 mM HEPES, pH 7, 5 mM dithio-
threitol, 0.1% CHAPS, 10% sucrose and 0.15 mM
Ac-DEVD-AMC and incubated for 15 min at
37‡C. The reaction was stopped in ice by adding
0.1 ml of 2% sodium acetate in 0.2 M acetic acid.
The samples were diluted with 2.5 ml of water and
the speci¢c cleavage of Ac-DEVD-AMC was moni-
tored by aminomethylcoumarin release using 370 nm
excitation and 455 nm emission wavelength. One unit
is de¢ned as the amount of enzyme activity cleaving
1.0 nmol of substrate per minute in the standard
conditions described. This activity will be simply re-
ferred to as caspase activity. In order to evaluate the
direct e¡ect of NO donors on the function of casp-
ases, an extract containing high caspase activity was
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prepared from cells incubated 6 h with 1 WM stauro-
sporine. Caspase activity in this extract was assayed
in the presence of the indicated concentration of NO
donors.
2.3. Other assays
To measure the intracellular level of reduced glu-
tathione (GSH), the cells from ¢ve dishes were col-
lected, pooled and lysed in 0.6 N perchloric acid.
GSH in the acid extract was determined by capillary
electrophoresis, as previously described [19]. Pro-
tein concentration was measured by Coomassie stain-
ing.
3. Results
The e¡ect of NO on cell death widely di¡ers de-
pending on the cell type [1^4]. In preliminary experi-
ments we observed that NO donors were toxic to
CEHC without causing the typical morphological
changes of apoptosis. A study of the dose-e¡ect of
SNAP on caspase activity and cell survival was then
carried out. Caspase activity was assayed following a
5 h incubation, whereas cell viability was measured
after 24 h (Fig. 1A). The treatment of CEHC with
SNAP caused a dose-dependent decrease of caspase
activity that accompanied cell death. In these experi-
ments caspase activity was not stimulated, and the
basal activity measured in cell extracts is evidently
due to background spontaneous apoptosis in cell cul-
tures.
Recently, it was demonstrated that NO directly
inhibits caspase-3 [8]. In agreement with these obser-
vations, SNAP, as well as the other NO donor mol-
ecules S-nitrosoglutathione (GSNO) and spermine-
NO (SpmNO), dose-dependently inhibited caspase
activity in extracts obtained from staurosporine-
treated CEHC (Fig. 1B). This in vitro inhibitory ef-
fect of NO donors is probably underestimated, be-
cause, in order to optimize caspase activity, DTT was
present in the assay mixture and DTT is known to
counteract the inhibitory e¡ect of NO on caspases
[9]. Fig. 1C shows that several NO donor molecules
that release NO as nitrosothiols (SNAP, GSNO) or
with di¡erent mechanisms (SpmNO, SNP), inhibited
the basal caspase activity in whole CEHC.
Subsequently, the e¡ect of NO donors on caspase
activity was studied in intact cells undergoing apop-
tosis. Staurosporine is known to cause apoptosis in
virtually all cell types. The treatment of CEHC with
1 WM staurosporine caused an early and marked ac-
tivation of caspase activity, that increased more than
tenfold within 6 h (Fig. 2A). Caspase activity from
extracts of staurosporine-treated CEHC was lowered
by about 40, 65 or 68% when the cells were cultured
Fig. 1. Nitric oxide inhibits caspase activity of CEHC. (A)
CEHC were treated with the indicated doses of SNAP. Caspase
activity was measured following a 5 h incubation, while cell
survival was determined after 24 h. The data are expressed as
% of the control values measured in untreated cells. The con-
trol values were 0.16 þ 0.03 units/mg of protein (n = 4) for
caspase activity and 91 þ 3% (n = 4) for survival. The data are
means þ S.E. of four determinations. (B) Extracts obtained from
staurosporine-treated CEHC were assayed in the presence of
the indicated concentrations of NO donor molecule. Caspase
activity in the absence of any NO donor was 2.35 units/mg of
protein. The graph reports the mean and the range of results
obtained in two separate experiments. (C) Caspase activity was
measured in CEHC incubated for 5 h in the presence of 1 mM
of SNAP, GSNO or SpmNO or 0.1 mM SNP. Data are means
þ S.E. of four determinations.
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in the presence of 1 mM GSNO, SNAP or SNP,
respectively. A greater inhibition was obtained
when CEHC were treated with 300 WM DEVD-
CHO, a caspase inhibitor (Fig. 2B). DEVD-CHO
also inhibited the death of staurosporine-treated
CEHC, indicating that caspase activation was su⁄-
cient to mediate cell death in this model (Fig. 2C).
On the other hand, while they inhibited caspase ac-
tivity, NO donors did not increase cell survival after
staurosporine treatment but, on the contrary, they
increased cell death. As expected, DEVD-CHO did
not give any protection against NO-induced cytotox-
icity (data not shown).
Caspase activation has a pivotal role in the execu-
tion phase of apoptosis [10] and one can speculate
that by blocking NO toxicity, its potential antiapop-
totic capabilities, mediated by caspase inhibition,
may also be exerted in cells sensitive to NO-induced
toxicity. In order to test this hypothesis, we searched
for treatments able to protect CEHC against NO-
induced injury and found that NAC inhibited
CEHC death caused by NO donors. Incubation of
Fig. 3. E¡ect of NAC on cell death and inhibition of caspase
activity caused by SNAP. (A) CEHC were incubated for 24 h
with the indicated concentrations of SNAP without any further
treatment or in the presence of 10 mM NAC. (B) The cells
were incubated for 5 h in the presence of the indicated treat-
ments (concentrations were: 1 mM SNAP, 0.1 mM SNP, 10
mM NAC), then collected for the determination of GSH con-
tent. (C) CEHC were treated with 1 WM staurosporine alone
(stauro) or together with 1 mM SNAP. The cells were incu-
bated for 5 h in the presence of the indicated concentrations of
NAC, and then collected for caspase assay. Results reported in
all the panels are means þ S.E. of four determinations.
Fig. 2. NO donors inhibit caspase activity but not cell death of
staurosporine-treated CEHC. (A) CEHC were incubated for the
indicated times without any treatment (control) or in the pres-
ence of 1 WM staurosporine, then caspase activity was meas-
ured. (B) CEHC were incubated for 5 h without any treatment
(control) or with staurosporine alone (stauro) or with stauro-
sporine together with 1 mM GSNO or 1 mM SNAP or 0.1
mM SNP or 0.3 mM DEVD-CHO (DEVD). (C) Untreated
(control) and staurosporine-treated CEHC were incubated with-
out any further treatment or in the presence of 1 mM GSNO
or 1 mM SNAP or 0.1 mM SNP or 0.3 mM DEVD-CHO
(DEVD). Cell survival was measured after 24 h of incubation.
All the panels report the means þ S.E. of results obtained in
multiple determinations (three to six).
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CEHC in the presence of 10 mM NAC did not a¡ect
the survival of these cells, but restored the viability of
SNAP-treated cells (Fig. 3A). The cytoprotective ac-
tion of NAC, however, decreased at high concentra-
tions of the NO donor. Interestingly, NAC also
blocked the depletion of cellular GSH triggered by
NO donors (Fig. 3B), suggesting that GSH depletion
could be involved in the toxicity of NO in CEHC, as
observed in di¡erent cell types [2,20,21].
Although SNAP toxicity was reduced in the pres-
ence of NAC, the NO donor molecule continued to
inhibit caspase activity. In fact, at the concentration
of 10 mM, NAC only slightly attenuated the inhib-
ition of caspase activity exerted by 1 mM SNAP in
whole cells treated with staurosporine (Fig. 3C). At
higher NAC concentration, however, the inhibitory
e¡ect of SNAP on caspase activity was lost.
In staurosporine-treated CEHC, NAC alone did
not signi¢cantly a¡ect survival or caspase activity,
but when 2 mM SNAP was present at the same
time, survival increased from less than 20% to about
50% (51 þ 6%, n = 6). In the meantime, caspase activ-
ity was reduced by more than 50% (Fig. 4). If NAC
was omitted from the medium, SNAP continued to
reduce the caspase activity induced by staurosporine,
while cell death was not inhibited, but actually en-
hanced, according to separate experiments depicted
in Fig. 2C. Similar results were obtained when SNP
was used as NO donor (not shown).
4. Discussion
Growing evidence has shown that NO may have
either cytotoxic or cytoprotective e¡ects [1^4]. Sev-
eral mechanisms may participate to NO-induced tox-
icity [2,22,23]: NO may react with molecular oxygen
or with the superoxide radical, generating potent cell
damaging agents [24^26]. NO also inhibits DNA syn-
thesis and repair, antioxidant enzymes and mito-
chondrial respiration [22,23,27] and depletes the cel-
lular GSH [2,20,21]. Furthermore, induction of p53
[28] and of mitochondrial permeability transition [29]
are mechanisms that can mediate NO-induced apop-
tosis in sensitive cells. On the other hand, antioxidant
capability [30], induction of stress [31] or antiapop-
totic [32] proteins and increased cGMP content
[15,33] are the main mechanisms that have been im-
plicated in the cytoprotective e¡ect of NO.
The ¢nding that NO can directly inhibit caspases
[8,9,11^16] has revealed another major mechanism
that can be involved in the e¡ects of NO on cell
death. The members of the caspase protease family
represent the executioners of the cell death program,
and their activation may be considered the ‘point of
no return’ in apoptosis [10]. The e¡ect of NO on
caspases is likely to be a primary event mediating
its inhibition of apoptosis in appropriate cell models.
Inhibition of caspases may also be important in de-
termining the shape of cell death [11]. In fact, it
seems reasonable to think that NO may induce cell
death accompanied by the typical features of apop-
tosis, as happens in some cell models [1^4], only
when the activation of caspases prevails over the in-
hibitory e¡ects of NO.
In CEHC, relatively high concentrations of NO
donor molecules are cytotoxic. However, their toxic-
ity is inhibited by NAC, in agreement with other
reports indicating a protective e¡ect of thiols against
NO-induced injury [34^36]. Cell death is accompa-
nied by a drastic reduction in GSH level, as observed
in other cell models [20,21], that is fully prevented by
NAC, suggesting that GSH depletion may be respon-
sible for NO toxicity. The cytoprotective action of
NAC could be mediated by its ability to preserve
cellular levels of GSH, that, in turn, could inhibit
the toxic e¡ects of NO [27]. However, it cannot be
ruled out that GSH depletion is a consequence of cell
death and that NAC promotes cell survival by mech-
Fig. 4. In the presence of 10 mM NAC, the NO donor SNAP
attenuates staurosporine-induced apoptosis of CEHC. CEHC
were treated as indicated, then caspase activity was measured
after 5 h and cell survival after 24 h of incubation. Results are
means þ S.E. of four determinations.
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anisms independent of GSH [37]. Further work is
required to answer this question.
NO donors do not cause CEHC apoptosis, since
their toxic e¡ect is not accompanied with activation
of caspases, whose activity is actually decreased. NO
also inhibits caspase activity stimulated by stauro-
sporine, a universal inducer of apoptosis. This e¡ect
of NO, however, does not result in protection against
staurosporine-induced apoptosis, as observed in the
presence of the caspase inhibitor DEVD-CHO, prob-
ably because NO itself is toxic. Actually, SNAP and
other NO donors increase the death of staurospor-
ine-treated CEHC. However, in the presence of 10
mM NAC, that protects CEHC from NO toxicity,
SNAP yet inhibits caspase activity, demonstrating
that this inhibition is not a simple unspeci¢c conse-
quence of cytotoxicity, but an independent event that
can be separated from cell death. As a consequence,
in the presence of 10 mM NAC the antiapoptotic
power of NO may be exerted, and SNAP attenuates
cell death induced by staurosporine.
The chemistry of NO is extraordinarily complex,
and its fate in the cell is determined by interaction
with several kind of compounds, especially oxidants
or thiols [7,38^43]. The inhibition of caspase activity
by SNAP in the presence of NAC in vivo is quite
unexpected, because thiol compounds should com-
petitively counteract the S-nitrosylation of caspase
enzymes as described in in vitro experiments [9,12^
14]. Actually, in the presence of high concentrations
of NAC (s 10 mM) the inhibitory e¡ect of SNAP
against caspase activity is lost, but at NAC concen-
tration of 10 mM this e¡ect is at least partially re-
tained. To explain this fact, it should be considered
that thiol-bearing compounds such as NAC act as
bu¡ering agents for NO and not as scavengers, be-
cause S-nitrosothiols are not stable compounds and
decompose, again yielding NO [2,38]. Consequently,
the presence of NAC, both directly and by preserving
GSH level, could stabilize NO in a nitrosothiol form
and render it available for a prolonged time. On the
contrary, in the absence of NAC, NO released from
donor molecules is more abundant, but its life is
probably much shorter. Thus, S-nitrosothiols may
be regarded as NO-storage compounds, and this
NO-bu¡ering e¡ect could also be responsible for
the inhibition of NO toxicity, avoiding an excessive
NO accumulation.
The complex redox chemistry [6,7,38^43] of NO
can modulate several cell processes including cell
death [34]. The reported data suggest that changes
in the redox environment allow for NO interconver-
sion from a cytotoxic into an antiapoptotic specie,
mediated by the e¡ects on caspase activity. Di¡er-
ences in the redox status could be responsible for
the divergent e¡ects of NO on cell death in di¡erent
cell types, highlighting another example of the dou-
ble edged role of NO in cell biology.
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